Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer

Since androgen receptor (AR) signaling is critically required for the development of prostate cancer (PCa), targeting AR axis has been the standard treatment of choice for advanced and metastatic PCa. Unfortunately, although the tumor initially responds to the therapy, treatment resistance eventuall...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lingfan, Chen, Junyi, Liu, Weipeng, Liang, Chaozhao, Hu, Hailiang, Huang, Jiaoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363598/
https://www.ncbi.nlm.nih.gov/pubmed/30775252
http://dx.doi.org/10.1016/j.ajur.2018.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363598/
https://www.ncbi.nlm.nih.gov/pubmed/30775252
http://dx.doi.org/10.1016/j.ajur.2018.11.002

Ejemplares similares